Alector shares surge 10.47% intraday after announcing Q4 2025 financial results on Feb 25, 2026.

miércoles, 1 de abril de 2026, 10:48 am ET1 min de lectura
ALEC--
Alector surged 10.47% intraday, driven by the company's announcement of its Q4 2025 financial results on February 25, 2026. Focused on clinical-stage therapies for neurodegenerative diseases, Alector utilizes its proprietary Alector Brain Carrier™ ABC platform for blood-brain barrier delivery.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios